APROLAN ODT olanzapine 10mg orodispersible tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

olanzapine, Quantity: 10 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

Olanzapine

Pharmaceutical form:

Tablet, orally disintegrating

Composition:

Excipient Ingredients: microcrystalline cellulose; mannitol; pregelatinised maize starch; crospovidone; sodium lauryl sulfate; aspartame; colloidal anhydrous silica; magnesium stearate; Guar Gum

Administration route:

Oral

Units in package:

28 tablet

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Treatment of schizophrenia and related psychoses. Short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar I disorder. Preventing recurrence of manic, mixed or depressive episodes in bipolar I disorder.

Product summary:

Visual Identification: Yellow coloured, round shaped tablets, convex on one side and flat on the other; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2011-02-17